Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT00901225Phase 2Completed
A Phase 2 trial of plerixafor in multiple myeloma (MM), non-Hodgkin lymphoma (NHL), Hodgkin lymphoma (HL), sponsored by Duke University. Started May 2009; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT00901225.